Medical Countermeasures Appili Therapeutics Reports Strong Preclinical Protection from ATI-1701 Tularemia VaccineGlobal Biodefense StaffAugust 11, 2025
Medical Countermeasures Pan-Coronavirus Drug Discovery Gets a Boost from Global AI Blind ChallengeGlobal Biodefense StaffJuly 28, 2025
Are Common Cold Coronaviruses a Hidden Variable in COVID-19 Vaccine Effectiveness? Medical Countermeasures July 17, 2025 …
Mpox Antiviral Clinical Trial Advances as WHO Extends Global Emergency Medical Countermeasures July 17, 2025 …
Peptide-Based Monkeypox Vaccine Candidate Designed Using Viral Glycoprotein Target Medical Countermeasures July 14, 2025 …
Monoclonal Antibody Shows Broad SARS-CoV-2 Neutralization in Preclinical Study Medical Countermeasures July 8, 2025 …
New Multi-Epitope Mpox Vaccine Shows Strong Potential in Silico Medical Countermeasures July 8, 2025 …
Unlocking a New Target Against Crimean-Congo Hemorrhagic Fever Virus Medical Countermeasures July 3, 2025 …
Novel Oral Chitosan-Based Compound Shows Promise for Radiological Emergency Response Medical Countermeasures June 12, 2025 …
Single-Dose VSV Vaccine Fully Protects Mice Against Crimean-Congo Hemorrhagic Fever Medical Countermeasures June 5, 2025 …
Needle-Free Influenza Vaccines: HKUMed Advances New Live-Attenuated Platforms with Cross-Subtype Potential Medical Countermeasures May 9, 2025 …
New Monoclonal Antibodies Offer Hope for Universal Influenza Treatment Medical Countermeasures May 1, 2025 …
Innovative VLP-Based Vaccine Shows Promise Against Avian Influenza Medical Countermeasures April 30, 2025 …
Federal Scientists Use AI to Optimize Antibodies Against Mutations Medical Countermeasures April 7, 2025 …
W.H.O. Partner Program Allocates 238,000 Doses of Mpox Vaccine to Four Countries Medical Countermeasures March 19, 2025 …
Emergent BioSolutions Secures $27 Million in International Orders for Critical Medical Countermeasures Medical Countermeasures March 18, 2025 …
Tecovirimat Shown to Lack Efficacy as Treatment for Clade II Mpox Medical Countermeasures March 12, 2025 …
